市场调查报告书
商品编码
1291357
银质伤口敷料市场:2023-2028年全球行业趋势、份额、规模、增长、机会和预测Silver Wound Dressing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
全球银质伤口敷料的市场规模在2022年达到9.283亿美元。展望未来,IMARC集团预计到2028年市场规模将达到12.298亿美元,在2023-2028年期间表现出4.5%的增长率(CAGR)。
银质伤口敷料指的是局部伤口护理产品,它向伤口释放稳定数量的银,以提供抗菌和抗细菌作用。它们以屏障层、炭布敷料、泡沫敷料和水胶体的形式广泛存在。银质敷料可作为主要或辅助敷料,用于处理急性和慢性伤口的少量、中等或大量渗出物,如手术伤口、烧伤、压迫性溃疡、腿部溃疡和糖尿病足溃疡。它们也可以在压迫下使用,或与特定的局部和辅助疗法一起使用,以减少细菌负荷,遏制渗出物,并改善伤口肉芽组织的外观。近年来,银质伤口敷料在医疗保健行业获得了巨大的普及,用于治疗有局部感染或生物负担风险的急性或慢性伤口。
银质伤口敷料有助于预防和减少感染,提供广泛的抗菌活性,并改变伤口内的金属蛋白酶。因此,银质伤口敷料正在迅速取代传统的伤口护理和封闭产品,这也是推动市场增长的主要因素。除此之外,慢性伤口和烧伤发病率的上升,以及人们对先进的伤口护理治疗的认识的提高,都催化了对银制伤口敷料的需求。此外,癌症、糖尿病和心血管疾病(CVDs)等慢性病的发病率也有明显增加。与此同时,越来越多的病人接受手术,鼓励采用银质伤口敷料,以防止手术部位感染,促进伤口快速愈合。此外,一些关键的参与者正在进行大量投资,推出新的和创新的银质伤口敷料变体,以扩大他们的产品组合并获得竞争优势。其他因素,包括新兴的家庭保健趋势、道路事故案例的增加、人口老龄化、医疗保健基础设施的改善、技术进步和广泛的研究和开发(R&D)活动,也为市场增长提供了积极的推动力。
The global silver wound dressing market size reached US$ 928.3 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,229.8 Million by 2028, exhibiting a growth rate (CAGR) of 4.5% during 2023-2028.
Silver wound dressings refer to topical wound care products that release a steady amount of silver to the wound to provide antimicrobial and antibacterial action. They are widely available in the form of barrier layers, charcoal cloth dressings, foam dressings, and hydrocolloids. Silver dressings can be used as primary or secondary dressings to manage minimal, moderate, or heavy exudate in acute and chronic wounds, such as surgical wounds, burns, pressure ulcers, leg ulcers, and diabetic foot ulcers. They can also be utilized under compression or with select topical and adjunctive therapies to reduce the bacterial load, contain exudate, and improve the appearance of the wound's granulation tissue. In recent years, silver wound dressings have gained immense popularity in the healthcare industry to treat acute or chronic wounds with or at risk of local infection or bioburden.
Silver wound dressings help prevent and reduce infections, provide a wide range of antimicrobial activity, and alter metalloproteinases within wounds. As a result, silver wound dressings are rapidly replacing traditional wound care and closure products, which represents the primary factor driving the market growth. Besides this, the rising incidences of chronic wounds and burns and the growing awareness regarding advanced wound care treatment are catalyzing the demand for silver wound dressings. Additionally, there has been a significant increase in the prevalence of chronic conditions, such as cancer, diabetes, and cardiovascular diseases (CVDs). Along with this, the increasing number of patients undergoing surgeries is encouraging the adoption of silver wound dressings to prevent surgical site infections and promote faster wound healing. Furthermore, several key players are making heavy investments to launch new and innovative silver wound dressing variants to expand their product portfolio and gain a competitive edge. Other factors, including the emerging trend of home healthcare, rising cases of road accidents, aging population, improving healthcare infrastructure, technological advancements, and extensive research and development (R&D) activities, are also providing a positive thrust to the market growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global silver wound dressing market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, disease and end user.
Hydrofiber Silver Dressings
Nanocrystalline Silver Dressing
Silver Plated Nylon Fiber Dressing
Silver Nitrate Dressing
Silver Alginate Dressing
Others
Ulcers
Burns
Cuts and Lacerations
Others
Inpatient Facilities
Outpatient Facilities
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, Advanced Medical Solutions Group plc, B. Braun Melsungen AG, Cardinal Health Inc., Coloplast A/S, ConvaTec Group plc, Ferris Mfg. Corp., Hollister Incorporated, Integra LifeSciences, Medline Industries LP, Molnlycke Health Care AB and Smith & Nephew plc.